Display options
Cite
Koul HK, Pal M, Koul S. Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes Cancer. 2013;4(9):342-59doi: 10.1177/1947601913507951.
Koul, H. K., Pal, M., & Koul, S. (2013). Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes & cancer, 4(9), 342-59. https://doi.org/10.1177/1947601913507951
Koul, Hari K, et al. "Role of p38 MAP Kinase Signal Transduction in Solid Tumors." Genes & cancer vol. 4,9 (2013): 342-59. doi: https://doi.org/10.1177/1947601913507951
Koul HK, Pal M, Koul S. Role of p38 MAP Kinase Signal Transduction in Solid Tumors. Genes Cancer. 2013 Sep;4(9):342-59. doi: 10.1177/1947601913507951. PMID: 24349632; PMCID: PMC3863344.
Copy Download .nbib Format: NLM
Share it on

Genes Cancer. 2013 Sep;4(9):342-59. doi: 10.1177/1947601913507951.

Role of p38 MAP Kinase Signal Transduction in Solid Tumors.

Genes & cancer

Hari K Koul, Mantu Pal, Sweaty Koul

Affiliations

  1. Department of Biochemistry & Molecular Biology, LSU Health Sciences Center, Shreveport, LA, USA ; Feist-Weiller Cancer Center, Shreveport, LA, USA ; Veterans Administration Medical Center, Shreveport, LA, USA.
  2. Department of Biochemistry & Molecular Biology, LSU Health Sciences Center, Shreveport, LA, USA ; Veterans Administration Medical Center, Shreveport, LA, USA.
  3. Feist-Weiller Cancer Center, Shreveport, LA, USA ; Department of Urology, LSU Health Sciences Center, Shreveport, LA, USA.

PMID: 24349632 PMCID: PMC3863344 DOI: 10.1177/1947601913507951

Abstract

Mitogen-activated protein kinases (MAPKs) mediate a wide variety of cellular behaviors in response to extracellular stimuli. One of the main subgroups, the p38 MAP kinases, has been implicated in a wide range of complex biologic processes, such as cell proliferation, cell differentiation, cell death, cell migration, and invasion. Dysregulation of p38 MAPK levels in patients are associated with advanced stages and short survival in cancer patients (e.g., prostate, breast, bladder, liver, and lung cancer). p38 MAPK plays a dual role as a regulator of cell death, and it can either mediate cell survival or cell death depending not only on the type of stimulus but also in a cell type specific manner. In addition to modulating cell survival, an essential role of p38 MAPK in modulation of cell migration and invasion offers a distinct opportunity to target this pathway with respect to tumor metastasis. The specific function of p38 MAPK appears to depend not only on the cell type but also on the stimuli and/or the isoform that is activated. p38 MAPK signaling pathway is activated in response to diverse stimuli and mediates its function by components downstream of p38. Extrapolation of the knowledge gained from laboratory findings is essential to address the clinical significance of p38 MAPK signaling pathways. The goal of this review is to provide an overview on recent progress made in defining the functions of p38 MAPK pathways with respect to solid tumor biology and generate testable hypothesis with respect to the role of p38 MAPK as an attractive target for intervention of solid tumors.

Keywords: mitogen-activated protein kinase (MAPK); p38 signaling pathway; solid tumors

References

  1. EMBO J. 2006 Feb 22;25(4):713-26 - PubMed
  2. Exp Cell Res. 2004 May 1;295(2):497-511 - PubMed
  3. Hepatology. 1996 Feb;23(2):210-7 - PubMed
  4. J Biol Chem. 1995 Mar 31;270(13):7420-6 - PubMed
  5. Science. 1997 Jan 3;275(5296):90-4 - PubMed
  6. Mol Cell Biol. 1999 Jun;19(6):4028-38 - PubMed
  7. Cancer. 2003 Jun 15;97(12):3017-26 - PubMed
  8. Cancer Res. 2002 Nov 15;62(22):6724-30 - PubMed
  9. Cancer Res. 2006 Feb 15;66(4):2264-70 - PubMed
  10. Am J Respir Crit Care Med. 1998 Sep;158(3):958-62 - PubMed
  11. Pharmacol Rev. 2008 Sep;60(3):261-310 - PubMed
  12. J Immunol. 1998 Jan 15;160(2):920-8 - PubMed
  13. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10454-9 - PubMed
  14. Cancer Res. 1993 Nov 15;53(22):5365-9 - PubMed
  15. Oncogene. 2001 Aug 30;20(38):5359-65 - PubMed
  16. EMBO J. 2002 Dec 2;21(23):6473-82 - PubMed
  17. Cancer Res. 2003 May 15;63(10):2483-91 - PubMed
  18. J Investig Med. 1994 Dec;42(4):640-51 - PubMed
  19. Breast Cancer Res Treat. 2004 Jan;83(2):119-28 - PubMed
  20. Cancer Metastasis Rev. 2010 Mar;29(1):143-9 - PubMed
  21. Mol Biol Cell. 1999 Dec;10(12):4231-46 - PubMed
  22. J Urol. 1996 Apr;155(4):1233-8 - PubMed
  23. Oncogene. 1997 Nov 27;15(22):2705-16 - PubMed
  24. Carcinogenesis. 2006 Mar;27(3):437-45 - PubMed
  25. J Steroid Biochem Mol Biol. 2001 Jan-Mar;76(1-5):125-34 - PubMed
  26. J Clin Invest. 1999 Mar;103(6):851-8 - PubMed
  27. Cancer Res. 2007 Apr 15;67(8):3752-8 - PubMed
  28. Am J Pathol. 1993 Jun;142(6):1739-49 - PubMed
  29. Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):343-7 - PubMed
  30. J Biol Chem. 1999 Oct 22;274(43):30858-63 - PubMed
  31. Am J Respir Cell Mol Biol. 2002 May;26(5):558-64 - PubMed
  32. EMBO J. 2007 Sep 5;26(17):3957-67 - PubMed
  33. Mol Cancer Ther. 2002 Oct;1(12):1059-66 - PubMed
  34. Exp Cell Res. 2005 Aug 1;308(1):135-45 - PubMed
  35. Nat Immunol. 2008 Sep;9(9):1019-27 - PubMed
  36. Am J Pathol. 1993 May;142(5):1335-8 - PubMed
  37. Inflammation. 1996 Oct;20(5):461-9 - PubMed
  38. Br J Pharmacol. 2006 Feb;147 Suppl 2:S144-52 - PubMed
  39. J Biol Chem. 2005 Jul 8;280(27):25920-7 - PubMed
  40. J Biol Chem. 1996 May 10;271(19):11427-33 - PubMed
  41. Mol Cell Biol. 1999 May;19(5):3857-68 - PubMed
  42. FEBS Lett. 2003 Jul 3;546(1):37-44 - PubMed
  43. Oncogene. 2008 Mar 20;27(13):1916-29 - PubMed
  44. J Biol Chem. 2000 Jan 21;275(3):2103-14 - PubMed
  45. Int J Cancer. 1997 Jul 3;72(1):149-54 - PubMed
  46. J Biol Chem. 2012 Oct 19;287(43):36593-608 - PubMed
  47. Biochem J. 2000 May 15;348 Pt 1:93-101 - PubMed
  48. J Immunol. 2006 Mar 15;176(6):3635-41 - PubMed
  49. Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7259-64 - PubMed
  50. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3302-7 - PubMed
  51. Eur Urol. 2002 Feb;41(2):105-12 - PubMed
  52. Pharmacol Rev. 1998 Dec;50(4):515-96 - PubMed
  53. J Immunol. 1998 Nov 15;161(10):5681-6 - PubMed
  54. Curr Opin Biotechnol. 1995 Dec;6(6):657-61 - PubMed
  55. Mol Biol Cell. 2001 Jan;12(1):27-36 - PubMed
  56. Int J Oncol. 2009 Jun;34(6):1557-64 - PubMed
  57. Cancer Res. 2003 Sep 1;63(17):5454-61 - PubMed
  58. Am J Respir Crit Care Med. 1999 Feb;159(2):634-40 - PubMed
  59. J Pathol. 2006 Jul;209(3):298-306 - PubMed
  60. Cancer Res. 2009 Jun 1;69(11):4648-55 - PubMed
  61. Cancer. 2004 Apr 1;100(7):1388-96 - PubMed
  62. Mol Cell Biol. 2006 Mar;26(6):2118-29 - PubMed
  63. J Pathol. 2006 Feb;208(3):401-7 - PubMed
  64. Cancer Lett. 1998 Dec 25;134(2):155-62 - PubMed
  65. J Cell Sci. 2000 Jan;113 Pt 2:227-35 - PubMed
  66. Dig Dis Sci. 1997 Nov;42(11):2277-84 - PubMed
  67. PLoS One. 2012;7(11):e50071 - PubMed
  68. Science. 1996 Nov 15;274(5290):1194-7 - PubMed
  69. Nat Immunol. 2005 Nov;6(11):1087-95 - PubMed
  70. Am J Respir Cell Mol Biol. 1996 Jul;15(1):97-106 - PubMed
  71. Surgery. 1998 Aug;124(2):403-7; discussion 408 - PubMed
  72. Immunopharmacology. 2000 May;47(2-3):185-201 - PubMed
  73. Genes Dev. 2003 Aug 15;17(16):1969-78 - PubMed
  74. Front Biosci. 2008 May 01;13:3581-93 - PubMed
  75. Circ Res. 1997 Mar;80(3):383-92 - PubMed
  76. Anticancer Res. 2000 Nov-Dec;20(6B):4579-83 - PubMed
  77. Cancer Res. 2006 Nov 1;66(21):10487-96 - PubMed
  78. J Urol. 2003 Sep;170(3):787-90 - PubMed
  79. Physiol Rev. 2001 Apr;81(2):807-69 - PubMed
  80. Science. 2002 Dec 6;298(5600):1911-2 - PubMed
  81. Diagn Microbiol Infect Dis. 1990 Sep-Oct;13(5):397-404 - PubMed
  82. J Biol Chem. 2003 Dec 26;278(52):52231-9 - PubMed
  83. Science. 2002 Feb 15;295(5558):1291-4 - PubMed
  84. Oncogene. 2004 Apr 12;23(16):2838-49 - PubMed
  85. Ann N Y Acad Sci. 2004 Dec;1030:253-7 - PubMed
  86. Carcinogenesis. 2003 Jun;24(6):1067-75 - PubMed
  87. Am J Pathol. 2010 Aug;177(2):984-97 - PubMed
  88. Nature. 2000 Aug 17;406(6797):747-52 - PubMed
  89. J Transplant. 2012;2012:928954 - PubMed
  90. J Biol Chem. 1999 Mar 26;274(13):8788-96 - PubMed
  91. Biochem Pharmacol. 2002 Sep;64(5-6):765-70 - PubMed
  92. Am J Physiol Lung Cell Mol Physiol. 2000 Nov;279(5):L895-902 - PubMed
  93. EMBO J. 2005 Mar 23;24(6):1134-45 - PubMed
  94. Biochem Biophys Res Commun. 1997 Jun 27;235(3):533-8 - PubMed
  95. Oncogene. 1999 Jan 7;18(1):173-80 - PubMed
  96. Cancer Res. 2001 Jul 15;61(14):5432-40 - PubMed
  97. J Immunol. 2004 Dec 1;173(11):6928-37 - PubMed
  98. Science. 1996 May 31;272(5266):1347-9 - PubMed
  99. Cancer Res. 2006 Sep 1;66(17):8804-13 - PubMed
  100. BJU Int. 2003 Jan;91(1):99-104 - PubMed
  101. Biochem J. 1998 Dec 15;336 ( Pt 3):599-609 - PubMed
  102. J Immunol. 1998 Dec 1;161(11):6005-13 - PubMed
  103. Mol Reprod Dev. 1995 Dec;42(4):459-67 - PubMed
  104. J Biol Chem. 1996 Jul 26;271(30):17920-6 - PubMed
  105. Exp Cell Res. 2001 Dec 10;271(2):344-55 - PubMed
  106. Biochem Soc Trans. 2012 Feb;40(1):79-84 - PubMed
  107. Cancer Res. 2005 Dec 1;65(23):10984-91 - PubMed
  108. Genes Dev. 2009 Aug 1;23(15):1737-42 - PubMed
  109. J Pharmacol Exp Ther. 1999 Aug;290(2):621-8 - PubMed
  110. J Biol Chem. 1997 Aug 1;272(31):19509-17 - PubMed
  111. Nature. 1997 Mar 20;386(6622):296-9 - PubMed
  112. J Biol Chem. 2002 Oct 25;277(43):40390-6 - PubMed
  113. Ann N Y Acad Sci. 1993 Nov 30;696:149-70 - PubMed
  114. J Immunol. 1999 Apr 1;162(7):4246-52 - PubMed
  115. J Immunol. 1999 Dec 15;163(12):6403-12 - PubMed
  116. Oncogene. 2009 Jan 22;28(3):422-30 - PubMed
  117. J R Soc Promot Health. 2004 Sep;124(5):228-9 - PubMed
  118. Clin Exp Metastasis. 2004;21(6):525-33 - PubMed
  119. Curr Biol. 1996 May 1;6(5):606-13 - PubMed
  120. FASEB J. 2006 Apr;20(6):756-8 - PubMed
  121. J Biol Chem. 2007 Mar 2;282(9):6075-89 - PubMed
  122. J Biol Chem. 2011 Apr 29;286(17):15413-27 - PubMed
  123. J Biol Chem. 2000 Aug 25;275(34):26576-81 - PubMed
  124. Mol Cell Biol. 2013 Jan;33(1):127-35 - PubMed
  125. Am J Pathol. 1991 Mar;138(3):521-4 - PubMed
  126. J Biol Chem. 2002 Nov 22;277(47):45041-8 - PubMed
  127. Mol Endocrinol. 2007 Dec;21(12):2907-18 - PubMed
  128. Oncogene. 2003 Jul 10;22(28):4314-32 - PubMed
  129. J Biol Chem. 2003 Sep 5;278(36):33753-62 - PubMed
  130. Mol Cancer. 2004 Nov 17;3:31 - PubMed
  131. Oncogene. 2001 Dec 6;20(56):8066-74 - PubMed
  132. Clin Cancer Res. 2004 Nov 1;10(21):7335-46 - PubMed
  133. Am J Physiol Lung Cell Mol Physiol. 2006 Sep;291(3):L324-33 - PubMed
  134. Am J Pathol. 1996 Nov;149(5):1553-64 - PubMed
  135. J Biol Chem. 1997 Aug 29;272(35):22173-81 - PubMed
  136. Am J Pathol. 1999 Mar;154(3):755-65 - PubMed
  137. Nature. 1983 Mar 3;302(5903):33-7 - PubMed
  138. Nature. 2001 Jul 19;412(6844):346-51 - PubMed
  139. J Immunol. 2008 Apr 1;180(7):5075-82 - PubMed
  140. Mol Cell Proteomics. 2004 Aug;3(8):820-33 - PubMed
  141. Apoptosis. 2006 Nov;11(11):1969-75 - PubMed
  142. Mol Hum Reprod. 2006 Apr;12(4):225-32 - PubMed
  143. Int J Cancer. 2002 Mar 10;98(2):167-72 - PubMed
  144. J Urol. 2005 Nov;174(5):2022-6 - PubMed
  145. J Biol Chem. 1997 Apr 11;272(15):10110-6 - PubMed
  146. Eur J Cancer Prev. 2006 Feb;15(1):57-63 - PubMed
  147. Virchows Arch. 1998 May;432(5):407-13 - PubMed
  148. Cell Res. 2005 Jan;15(1):11-8 - PubMed
  149. Nature. 1999 Mar 18;398(6724):252-6 - PubMed
  150. Mol Cell. 2000 Jul;6(1):109-16 - PubMed
  151. Cell. 1991 Jan 25;64(2):327-36 - PubMed
  152. J Biol Chem. 2000 Jul 14;275(28):21086-93 - PubMed
  153. J Infect Dis. 1995 Mar;171(3):570-5 - PubMed
  154. Pharmacol Ther. 1999 May-Jun;82(2-3):389-97 - PubMed
  155. Free Radic Res. 1999 Oct;31(4):319-24 - PubMed
  156. Cancer. 2004 Feb 1;100(3):499-506 - PubMed
  157. J Biol Chem. 2000 Mar 10;275(10):7403-9 - PubMed
  158. J Biol Chem. 2000 Sep 8;275(36):27694-702 - PubMed
  159. Hum Pathol. 2002 Mar;33(3):299-306 - PubMed
  160. Cell Signal. 2006 Aug;18(8):1156-68 - PubMed
  161. J Biol Chem. 2001 Dec 14;276(50):46707-13 - PubMed
  162. J Biol Chem. 2006 Aug 4;281(31):22013-22020 - PubMed
  163. Agents Actions. 1993;39 Spec No:C67-9 - PubMed
  164. Science. 1997 Jun 13;276(5319):1702-5 - PubMed
  165. J Biol Chem. 1997 Sep 19;272(38):23668-74 - PubMed
  166. Prostate. 2003 May 1;55(2):128-39 - PubMed
  167. J Biol Chem. 2005 Jun 3;280(22):20995-1003 - PubMed
  168. Adv Cancer Res. 2004;92:95-118 - PubMed
  169. J Biol Chem. 1999 Mar 12;274(11):7095-102 - PubMed
  170. Biochem J. 2010 Aug 1;429(3):403-17 - PubMed
  171. Science. 1995 Nov 24;270(5240):1326-31 - PubMed
  172. Chem Rev. 2001 Aug;101(8):2449-76 - PubMed
  173. Regul Pept. 2002 Nov 15;109(1-3):141-8 - PubMed
  174. Mol Cell Biol. 1999 Jan;19(1):21-30 - PubMed
  175. Cancer Res. 1998 Mar 15;58(6):1135-9 - PubMed
  176. Cancer Res. 2002 Jul 1;62(13):3615-9 - PubMed
  177. Int J Oncol. 2003 Oct;23(4):1095-102 - PubMed
  178. Biochem Biophys Res Commun. 2003 Jul 25;307(2):332-7 - PubMed
  179. Clin Cancer Res. 2001 Aug;7(8):2513-8 - PubMed
  180. Curr Urol Rep. 2006 Jan;7(1):57-63 - PubMed
  181. Cancer Res. 2003 Apr 1;63(7):1684-95 - PubMed
  182. Cancer Res. 2010 Jan 15;70(2):832-41 - PubMed
  183. Mol Cell Biol. 2005 Dec;25(23):10454-64 - PubMed
  184. J Biol Chem. 1997 Aug 15;272(33):20490-4 - PubMed
  185. Int J Oncol. 2006 Jan;28(1):217-29 - PubMed
  186. Arch Pathol Lab Med. 2009 Nov;133(11):1850-6 - PubMed
  187. Clin Exp Metastasis. 2002;19(1):79-85 - PubMed
  188. Mol Cell Biol. 2002 Aug;22(16):5835-45 - PubMed
  189. Cell Cycle. 2007 Oct 15;6(20):2429-33 - PubMed
  190. Cell Cycle. 2006 Apr;5(8):824-8 - PubMed
  191. Int J Cancer. 2000 Nov 1;88(3):417-23 - PubMed
  192. Cell Commun Signal. 2004 Jun 25;2(1):5 - PubMed
  193. J Infect Dis. 1999 Apr;179(4):939-44 - PubMed
  194. Am J Physiol. 1999 May;276(5):L715-27 - PubMed
  195. Mol Cancer Ther. 2007 Apr;6(4):1212-22 - PubMed
  196. J Biol Chem. 2002 Dec 13;277(50):48379-85 - PubMed
  197. Cancer Detect Prev. 1997;21(1):36-43 - PubMed
  198. J Clin Invest. 1997 Mar 1;99(5):975-86 - PubMed
  199. Int J Oncol. 2004 Nov;25(5):1375-82 - PubMed
  200. J Biol Chem. 1999 Jan 29;274(5):2851-7 - PubMed
  201. Trends Cardiovasc Med. 1998 Jul;8(5):220-8 - PubMed
  202. Mol Cell Biol. 2003 Jun;23(11):3859-71 - PubMed
  203. J Biol Chem. 2002 Aug 30;277(35):32360-8 - PubMed
  204. J Inflamm. 1995;45(2):97-105 - PubMed
  205. Cell Cycle. 2005 Jan;4(1):118-20 - PubMed
  206. Science. 1995 Dec 22;270(5244):2008-11 - PubMed
  207. Cancer Res. 2001 Feb 15;61(4):1604-10 - PubMed
  208. Cancer Res. 1997 Oct 1;57(19):4177-82 - PubMed
  209. Trends Mol Med. 2004 Mar;10(3):125-9 - PubMed
  210. Int J Oncol. 2002 Jun;20(6):1297-303 - PubMed
  211. Cancer Res. 2001 Oct 15;61(20):7408-12 - PubMed
  212. Cancer Res. 2002 Mar 1;62(5):1549-54 - PubMed
  213. J Clin Oncol. 2005 Apr 10;23(11):2469-76 - PubMed
  214. Cancer Sci. 2003 Apr;94(4):328-33 - PubMed
  215. Cancer Res. 2006 May 1;66(9):4888-94 - PubMed
  216. Nature. 1994 Dec 22-29;372(6508):739-46 - PubMed
  217. Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 2):S72-9 - PubMed
  218. J Pharmacol Exp Ther. 2010 Aug;334(2):657-64 - PubMed
  219. J Urol. 1992 Sep;148(3):791-4 - PubMed
  220. Oncogene. 2006 May 18;25(21):2987-98 - PubMed
  221. Neoplasia. 2011 Feb;13(2):98-107 - PubMed
  222. Nature. 1996 Mar 7;380(6569):75-9 - PubMed
  223. J Urol. 1999 Apr;161(4):1359-63 - PubMed
  224. Am J Respir Cell Mol Biol. 1999 Apr;20(4):751-8 - PubMed
  225. Br J Cancer. 2006 Apr 24;94(8):1154-63 - PubMed
  226. Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034 - PubMed
  227. J Mol Biol. 2003 Feb 7;326(1):105-15 - PubMed
  228. J Lab Clin Med. 1995 May;125(5):618-25 - PubMed
  229. Biochem J. 2003 Aug 15;374(Pt 1):1-20 - PubMed
  230. Trends Pharmacol Sci. 2002 Jan;23(1):40-5 - PubMed
  231. J Biol Chem. 2003 Feb 21;278(8):5750-9 - PubMed
  232. Ann N Y Acad Sci. 2005 Nov;1059:76-85 - PubMed
  233. J Pharmacol Exp Ther. 2000 Apr;293(1):281-8 - PubMed
  234. Biochem Biophys Res Commun. 2000 Nov 19;278(2):484-92 - PubMed
  235. Drug Resist Updat. 2007 Jun;10(3):81-100 - PubMed
  236. J Biol Chem. 2000 Apr 21;275(16):12266-72 - PubMed
  237. J Biol Chem. 2005 Apr 15;280(15):14675-83 - PubMed
  238. Annu Rev Immunol. 2002;20:55-72 - PubMed
  239. Oncogene. 2000 Aug 17;19(35):4011-21 - PubMed
  240. J Biol Chem. 1995 Dec 15;270(50):30084-92 - PubMed
  241. Mol Cell Biol Res Commun. 1999 Jun;1(3):196-202 - PubMed
  242. J Biol Chem. 1998 Jan 16;273(3):1741-8 - PubMed
  243. Cell Signal. 2002 Jun;14(6):509-15 - PubMed
  244. J Immunol. 1998 Dec 15;161(12):6768-74 - PubMed
  245. Cell Signal. 2011 Dec;23(12):2013-20 - PubMed
  246. Exp Cell Res. 2009 May 1;315(8):1490-504 - PubMed
  247. Oncogene. 2009 Mar 5;28(9):1248-60 - PubMed
  248. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4355-9 - PubMed
  249. Oncogene. 2007 Aug 9;26(36):5267-79 - PubMed
  250. J Cell Biol. 2002 Jan 21;156(2):299-313 - PubMed
  251. Am J Physiol Renal Physiol. 2007 May;292(5):F1471-8 - PubMed
  252. J Biol Chem. 2007 Nov 30;282(48):34663-71 - PubMed
  253. Nat Genet. 2002 Jun;31(2):210-5 - PubMed
  254. Breast Cancer Res Treat. 2005 Nov;94(1):71-80 - PubMed
  255. Science. 2003 Mar 21;299(5614):1859-63 - PubMed
  256. Cell. 1998 Aug 21;94(4):491-501 - PubMed
  257. Apoptosis. 2007 Apr;12(4):731-41 - PubMed
  258. Liver Int. 2006 May;26(4):467-76 - PubMed
  259. Nature. 2012 Feb 05;482(7385):419-22 - PubMed
  260. Biochem Biophys Res Commun. 2001 Nov 2;288(3):521-7 - PubMed
  261. Int J Oncol. 2008 Jul;33(1):81-92 - PubMed
  262. EMBO J. 1996 Apr 15;15(8):1914-23 - PubMed
  263. EMBO J. 2003 Mar 17;22(6):1313-24 - PubMed
  264. J Biol Chem. 1997 Nov 28;272(48):30122-8 - PubMed
  265. J Biol Chem. 2002 Aug 30;277(35):31808-17 - PubMed
  266. Br J Cancer. 2002 Apr 8;86(7):1188-96 - PubMed
  267. Int J Biol Sci. 2009;5(1):44-51 - PubMed
  268. Ai Zheng. 2007 Jan;26(1):48-53 - PubMed
  269. FEBS J. 2012 Jul;279(13):2399-411 - PubMed
  270. Cancer Lett. 2004 Nov 25;215(2):239-47 - PubMed
  271. Nat Rev Drug Discov. 2003 Sep;2(9):717-26 - PubMed
  272. Mol Biol Cell. 2002 Mar;13(3):902-14 - PubMed
  273. Cell. 2009 Jan 23;136(2):235-48 - PubMed

Publication Types

Grant support